TAK-875 reduced the body weight and inflammatory factors, inhibited the insulin resistance, rebalanced the number and distribution of α or β-cells, and inhibited the islet cell apoptosis and of the expression of TLR4-NF-κB subunit P65 of obese rats. Here, NFKB1 is linked to Insulin resistance.